Journal menu

open access
Oncology Therapeutics and Drug Development

Peer-Reviewed Bi-Annual (Two issues per year)
Submit
Manuscript
Mail
Us
×

Contact Emails

cancerjournal@globalmeetx.net
support@globalmeetx.com
editorial@globalmeetx.com
finance@globalmeetx.com
Article Processing
Charges
Peer
Review Peer Review Icon
Editorial
Tracker
LINC02471: A Novel Diagnostic and Prognostic Biomarker Correlated with Immune Infiltration in KIRP
Research Article - Volume: 1, Issue: 1, 2026 (March)
LINC02471: A Novel Diagnostic and Prognostic Biomarker Correlated with Immune Infiltration in KIRP Download PDF
*Correspondence to: , Department of Clinical Laboratory, Guangyuan Central Hospital, Guangyuan, China. E-Mail:
Received: January 21, 2026; Manuscript No: ; Editor Assigned: January 23, 2026; PreQc No: (PQ); Reviewed: February 02, 2026; Revised: February 04, 2026; Manuscript No: (R); Published: March 17, 2026

Citation: Chen D, Jiang X, Wei L, Meng Z, Li D (2026). LINC02471: A Novel Diagnostic and Prognostic Biomarker Correlated with Immune Infiltration in KIRP. Oncol. Ther. Drug Dev. . Vol.1 Iss.1, March (2026), pp:6-13.
Copyright: © 2026 . This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.